Background Image
Table of Contents Table of Contents
Previous Page  51 / 64 Next Page
Information
Show Menu
Previous Page 51 / 64 Next Page
Page Background

AFRICA

S49

CVJAFRICA • Volume 26, No 2, H3Africa Supplement, March/April 2015

associates with atrial fibrillation and ischemic stroke.

Nat Genet

2009;

41

(8): 876–878.

96. Bilguvar K, Yasuno K, Niemelä M, Ruigrok YM, von Und Zu

Fraunberg M, van Duijn CM,

et al

. Susceptibility loci for intracra-

nial aneurysm in European and Japanese populations

. Nat Genet

2008;

40

(12): 1472–1477.

97. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko

YS,

et al

. Genome-wide association studies of stroke.

N Engl J Med

2009;

360

(17): 1718–1728.

98. Yamada Y, Fuku N, Tanaka M, Aoyagi Y, Sawabe M, Metoki N,

et

al.

Identification of CELSR1 as a susceptibility gene for ischemic

stroke in Japanese individuals by a genome-wide association study.

Atherosclerosis

2009;

207

(1): 144–149.

99. Zhang W, Chen Y, Liu P, Chen J, Song L, Tang Y,

et al

. Variants on

chromosome 9p21.3 correlated with ANRIL expression contribute to

stroke risk and recurrence in a large prospective stroke population

.

Stroke

2012;

43

(1): 14–21.

100. Matsushita T, Ashikawa K, Yonemoto K, Hirakawa Y, Hata J, Amitani

H,

et al.

Functional SNP of ARHGEF10 confers risk of atherothrom-

botic stroke.

Hum Mol Genet

2

010;

19

(6): 1137–1146.

101. International Stroke Genetics Consortium (ISGC); Wellcome Trust

Case–Control Consortium 2 (WTCCC2), Bellenguez C, Bevan S,

Gschwendtner A, Spencer CC,

et al

. Genome-wide association study

identifies a variant in HDAC9 associated with large vessel ischemic

stroke.

Nat Genet

2012;

44

(3): 328–333.

102. Holliday EG, Maguire JM, Evans TJ, Koblar SA, Jannes J, Sturm JW,

et

al

. Common variants at 6p21.1 are associated with large artery athero-

sclerotic stroke.

Nat Genet

2012;

44

(10): 1147–1151.

103. Zhang Y, Tong Y, Zhang Y, Ding H, Zhang H, Geng Y,

et al

. Two

novel susceptibility SNPs for ischemic stroke using exome sequencing in

Chinese Han population

. Mol Neurobiol

2014;

49

(2): 852–862.

104. Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY. Association

of PAI-1 4G/5G and -844G/A gene polymorphism and changes in

PAI-1/tPA levels in stroke: a case-control study.

J Stroke Cerebrovasc

Dis

2007;

16

(4): 153–9.

105. Saidi S, Slamia LB, Ammou SB, Mahjoub T, Almawi WY. Association

of apolipoprotein E gene polymorphism with ischemic stroke involv-

ing large-vessel disease and its relation to serum lipid levels.

J Stroke

Cerebrovasc Dis

2007;

16

(4): 160–166.

106. Saidi S, Mahjoub T, Slamia LB, Ammou SB, Al-Subaie AM, Almawi

WY. Association of human platelet alloantigen 1 through 5 polymor-

phisms with ischemic stroke.

Cerebrovasc Dis

2008;

25

(1-2): 81–86.

107. Saidi S, Mahjoub T, Slamia LB, Ammou SB, Al-Subaie AM, Almawi

WY.

P

olymorphisms of the human platelet alloantigens HPA-1, HPA-2,

HPA-3, and HPA-4 in ischemic stroke.

Am J Hematol

2008;

83

(7):

570–573.

108. Saidi S, Zammiti W, Slamia LB, Ammou SB, Almawi WY, Mahjoub

T. Interaction of angiotensin-converting enzyme and apolipoprotein E

gene polymorphisms in ischemic stroke involving large-vessel disease.

J

Thromb Thrombol

27

(1): 68–74. Epub 2007 Nov 21.

109. Saidi S, Mallat SG, Almawi WY, Mahjoub T. Association between

renin–angiotensin–aldosterone system genotypes and haplotypes and

risk of ischemic stroke of atherosclerotic etiology.

Acta Neurol Scand

2009.

119

(6): 356–363.

110. Saidi S, Mallat SG, Almawi WY, Mahjoub T. Endothelial nitric oxide

synthase Glu298Asp, 4b/a, and

-786T

>

C

gene polymorphisms and the

risk of ischemic stroke.

Acta Neurol Scand

2010;

121

(2): 114–119.

111. Saidi S, Mahjoub T, Almawi WY. Aldosterone synthase gene (

CYP11B2

)

promoter polymorphism as a risk factor for ischaemic stroke in Tunisian

Arabs.

J Renin Angiotensin Aldosterone Syst

11

(3): 180–186.

112. Mourad H, Fadel W, El Batch M, Rowisha M. Heamostatic and genetic

predisposing factors for stroke in children with sickle cell anemia.

Egypt

J Immunol

2008;

15

(1): 25–37.

113. Marshall PA, Adebamowo CA, Adeyemo AA, Ogundiran TO, Strenski

T, Zhou J,

et al.

Voluntary participation and comprehension of

informed consent in a genetic epidemiological study of breast cancer in

Nigeria.

BMC Med Ethics

2014;

15

: 38.

114. Olaitan PB, Odesina V, Odesina V, Ademola S, Fadiora SO, Oluwatosin

OM, Reichenberger EJ. Recruitment of Yoruba families from Nigeria

for genetic research: experience from a multisite keloid study.

BMC Med

Ethics

2014;

15

: 65.

115. Fagbemiro L, Adebamowo C. Knowledge and attitudes to personal

genomics testing for complex diseases among Nigerians.

BMC Med

Ethics

2014;

15

: 34.

116. Howard G, Wagenknecht LE, Kernan WN, Cushman M, Thacker EL,

Judd SE,

et al.

Racial differences in the association of insulin resistance

with stroke risk: the REasons for Geographic And Racial Differences in

Stroke (REGARDS) study.

Stroke

2014;

45

(8): 2257–2262.

117. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ,

et al

. The reasons for geographic and racial differences in stroke study:

objectives and design

. Neuroepidemiology

2005;

25

(3): 135–143.